• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Cafepharma Playground

There is more to life than your job, so come to the Cafepharma Playground when you need a break and want to talk about whatever is on your mind. Registered posting only
Replies
47
Views
3K